摘要
目的:比较神经外科手术中瑞芬太尼和硝普钠(SNP)控制性降压的效果。方法:60例择期开颅手术病人,随机分为瑞芬太尼组(R组)和SNP组(S组)。两组病人麻醉诱导及维持方法相同。R组以瑞芬太尼0.1~0.5μg/kg·min维持降压;S组以SNP 0.5~3μg/kg·min维持降压,均将平均动脉压(MAP)降至60~65mmHg,持续60min。观察两组病人术中MAP、心率(HR)变化以及失血量及清醒拔管时间。结果:降压实施后两组病人的MAP均达预定目标,组间比较差异无显著意义(P〉0.05)。降压期间R组HR显著低于降压前(P〈0.05),而S组显著高于降压前(P〈0.05),组间比较差异非常显著(P〈0.05)。两组病人失血量及清醒拔管时间差异无显著意义。结论:神经外科手术中应用瑞芬太尼行控制性降压安全、有效,且优于硝普钠。
Objective:To compare effects of remifentanil and sodium nitroprusside(SNP) for controlled hypotension during neurosurgical operation.Methods:60 patients with craniotomy were randomly devided into group R(30 cases) and group S(30 cases).Anesthesia induction and maintenance in both groups were using the same method.Group R were infused with remifentanil 0.1~0.5μg/kg·min and group S were infused with SNP 0.5~3μg/kg·min for controlled hypotension.The target of controlled hypotension was fixed at MAP 60~65mmHg,which was maintained for 60 minutes.The hemodynamic changes in two groupswere recorded during surgery and amount of blood loss,extubation time were also compared.Results:The patients in both groups could maintain MAP at 60~65mmHg during controlled hypotension.There wasn't significant difference during controlled hypotension between two groups(P〉0.05).HR was significantly reduced in R group compared with pre-controlled hypotension(P〈0.05) and was significantly increased in S group during controlled hypotension(P〈0.05).The amount of blood loss and extubation time weren't significant difference between two groups.Conclusion:Remifentanil is a safe and effective drug for controlled hypotension in neurosurgical operation and its clinical efficacy is better than that of sodium nitroprusside.
出处
《内蒙古医学院学报》
2009年第4期385-387,共3页
Acta Academiae Medicinae Neimongol
关键词
瑞芬太尼
硝普钠
控制性降压
神经外科手术
remifentanil
sodium nitroprusside
controlled hypotension
neurosurgery